In endometrial cancer cells harboring activated mutations of FGFR2, knockdown of FGFR2 using short hairpin (sh) RNA or treatment with a pan-FGFR inhibitor, PD173074, caused cell cycle arrest and cell death [15]. Here, FGFR2 is linked to endometrial cancer.